Strategic funding Recent $5M strategic funding round and new CEO indicate expansion momentum and investor confidence. Approach: engage investor-backed growth conversations, offer scaled deployment options, and align with funding timelines for hospital integrations and regional expansion.

Clinical workflow Product focuses on real-time analytics, decision support, and bedside alerts for sepsis and critical care. Sales opportunities exist with ICU teams, EDs, and ORs seeking to reduce costs and improve patient outcomes through workflow-embedded analytics.

Mayo Clinic tech Licensed Mayo Clinic technologies and over 1,000 rules suggest strong credibility. Target health systems that value Mayo-derived CDS capabilities and look for validated, high-assurance clinical decision support, including integration with existing Mayo-based infrastructures.

European expansion Past European market activity and CE Marking indicate readiness for international deployments. Pursue hospitals and regional health networks in Europe and other regions requiring CE-certified clinical analytics and cross-border SaaS licensing.

Financing to scale Current revenue range and $19M funding position the company for scale but with modest employee count. Fit for mid-market hospitals and health systems seeking cost-effective, scalable cloud and license-based CDS tools with rapid time-to-value and service integration.